Loading...

LXRX LEXICON PHARMACEUTICALS INC Earnings Reports 8-K Filing

LXCN

LXRX

LEXICON PHARMACEUTICALS INC

(LXRX)

2025 8-K

Stock Sale Agreement

Stock Sale Agreement

Financial Results Report

Financial Statements

Equity Offerings

Financial Statements

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Filing with Quantitative Data

Filing with Quantitative Data

Filing with Quantitative Data

Capital Structure Change

Private Placement

Contract Renewal

Quantitative Data

External Links:

On November 6, 2025, Lexicon Pharmaceuticals, Inc. reported its financial results for the quarter ended September 30, 2025. This filing is significant for investors as it provides crucial insights into the company's financial performance.

AI Assistant

LEXICON PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.